Level Chart

Level Chart

Basic Info

Boston Scientific Corp (BSX) - MedSurg Organic Revenue Growth is at 5.70%, compared to 6.50% last quarter and 5.30% last year. This is lower than the long term average of 7.93%.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 5.70%
Latest Period Mar 2026
Last Updated Jul 29 2026, 08:30 EDT
Next Release Oct 21 2026, 08:30 EDT (E)
Long Term Average 7.93%
Average Growth Rate -86.08%
Value from Last Quarter 6.50%
Change from Last Quarter -12.31%
Value from 1 Year Ago 5.30%
Change from 1 Year Ago 7.55%
Frequency Quarterly
Unit Percent
Adjustment N/A
Download Source File

Historical Data

View and export this data back to 2019. Start Trial.
Date Value
March 31, 2026 5.70%
December 31, 2025 6.50%
September 30, 2025 7.60%
June 30, 2025 7.00%
March 31, 2025 5.30%
December 31, 2024 7.00%
September 30, 2024 7.70%
June 30, 2024 7.60%
March 31, 2024 7.80%
December 31, 2023 8.90%
September 30, 2023 9.40%
June 30, 2023 8.80%
March 31, 2023 13.40%
Date Value
December 31, 2022 8.50%
September 30, 2022 9.80%
June 30, 2022 4.80%
March 31, 2022 8.00%
December 31, 2021 9.40%
September 30, 2021 9.40%
June 30, 2021 60.70%
March 31, 2021 9.50%
December 31, 2020 1.10%
September 30, 2020 -1.90%
June 30, 2020 -28.40%
March 31, 2020 2.10%
December 31, 2019 10.60%

Basic Info

Boston Scientific Corp (BSX) - MedSurg Organic Revenue Growth is at 5.70%, compared to 6.50% last quarter and 5.30% last year. This is lower than the long term average of 7.93%.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 5.70%
Latest Period Mar 2026
Last Updated Jul 29 2026, 08:30 EDT
Next Release Oct 21 2026, 08:30 EDT (E)
Long Term Average 7.93%
Average Growth Rate -86.08%
Value from Last Quarter 6.50%
Change from Last Quarter -12.31%
Value from 1 Year Ago 5.30%
Change from 1 Year Ago 7.55%
Frequency Quarterly
Unit Percent
Adjustment N/A
Download Source File

Related Securities

Symbol Name Change %
BSX Boston Scientific Corp. 1.81%